4//SEC Filing
Ho Carole 4
Accession 0001714899-24-000235
CIK 0001714899other
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 4:44 PM ET
Size
8.9 KB
Accession
0001714899-24-000235
Insider Transaction Report
Form 4
Ho Carole
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2024-11-25$0.68/sh+17,845$12,135→ 136,655 total - Exercise/Conversion
Stock Option (right to buy)
2024-11-25−17,845→ 107,155 totalExercise: $0.68Exp: 2025-08-20→ Common Stock (17,845 underlying)
Holdings
- 25,000(indirect: See footnote)
Common Stock
- 183,219(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Includes 118,810 Unvested RSUs.
- [F2]The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.
- [F3]The shares are held of record by the Rohatgi-Ho Irrevocable GST Trust, for which Reporting Person serves as trustee.
- [F4]The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days.
Documents
Issuer
Denali Therapeutics Inc.
CIK 0001714899
Entity typeother
Related Parties
1- filerCIK 0001724605
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 4:44 PM ET
- Size
- 8.9 KB